Vincerx Pharma Announces Compelling Clinical Efficacy of Eni

Investigators from the National Institutes of Health report 2 partial responses in 3 peripheral T-cell lymphoma patients and 1 PR in 2 double-hit diffuse large b-cell lymphoma patients in ongoing...

Related Keywords

Germany , Palo Alto , California , United States , Joyce Lonergan , Ahmed Hamdy , Ian Flinn , Gabriela Jairala , Lifesci Advisors , Exchange Commission , Nasdaq , National Institutes Of Health , Globenewswire Inc , Securities Exchange , Vincerx Pharma Inc , Chief Executive Officer , Scientific Advisory Board , Chief Scientific Officer , Bone Oncology , Versaptx Platform , Securities Act , Securities Exchange Act , Sci Advisors ,